Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
2.
Lab Invest ; 102(4): 401-410, 2022 04.
Article in English | MEDLINE | ID: mdl-34893758

ABSTRACT

The oncoprotein Smoothened (SMO), a Frizzled-class-G-protein-coupled receptor, is the central transducer of hedgehog (Hh) signaling. While canonical SMO signaling is best understood in the context of cilia, evidence suggests that SMO has other functions in cancer biology that are unrelated to canonical Hh signaling. Herein, we provided evidence that elevated levels of human SMO show a strong correlation with elevated levels of insulin-like growth factor 1 receptor (IGF1R) and reduced survival in diffuse large B-cell lymphoma (DLBCL). As an integral component of raft microdomains, SMO plays a fundamental role in maintaining the levels of IGF1R in lymphoma and breast cancer cells as well IGF1R-associated activation of protein kinase B (AKT). Silencing of SMO increases lysosomal degradation and favors a localization of IGF1R to late endosomal compartments instead of early endosomal compartments from which much of the receptor would normally recycle. In addition, loss of SMO interferes with the lipid raft localization and retention of the remaining IGF1R and AKT, thereby disrupting the primary signaling context for IGF1R/AKT. This activity of SMO is independent of its canonical signaling and represents a novel and clinically relevant contribution to signaling by the highly oncogenic IGF1R/AKT signaling axis.


Subject(s)
Insulin-Like Growth Factor I , Proto-Oncogene Proteins c-akt , Hedgehog Proteins/metabolism , Humans , Proto-Oncogene Proteins c-akt/metabolism , Receptor, IGF Type 1/metabolism , Receptors, G-Protein-Coupled/metabolism , Signal Transduction/physiology , Smoothened Receptor/metabolism
4.
Blood ; 127(5): 605-15, 2016 Feb 04.
Article in English | MEDLINE | ID: mdl-26603838

ABSTRACT

GLI1 oncogene has been implicated in the pathobiology of several neoplasms including diffuse large B-cell lymphoma (DLBCL). However, mechanisms underlying GLI1-increased activity in DLBCL are poorly characterized. Herein, we demonstrate that IKKß phosphorylates GLI1 in DLBCL. IKKß activation increased GLI1 protein levels and transcriptional activity, whereas IKKß silencing decreased GLI1 levels and transcriptional activity. Tumor necrosis factor-α (TNFα) mediated IKKß activation-impaired GLI1 binding with the E3 ubiquitin ligase-ITCH, leading to decreased K48-linked ubiquitination/degradation of GLI1. We found 8 IKKß-dependent phosphorylation sites that mediate GLI1 stability. Mutating or deleting these residues facilitated GLI1-ITCH interaction and decreased the protective effect of TNFα on GLI1 stability. IKKß-GLI1 crosstalk is significant because combined inhibition of both molecules resulted in synergistic suppression of DLBCL viability in vivo and in vitro. By linking IKKß-mediated nuclear factor-κB activity with GLI1, we identified a crosstalk between these 2 pathways that can inform the design of novel therapeutic strategies in DLBCL.


Subject(s)
I-kappa B Kinase/metabolism , Lymphoma, Large B-Cell, Diffuse/metabolism , Transcription Factors/metabolism , Cell Line, Tumor , Cell Survival , Humans , Lymphoma, Large B-Cell, Diffuse/genetics , NF-kappa B/metabolism , Phosphorylation , Protein Stability , Repressor Proteins/metabolism , Transcription Factors/chemistry , Ubiquitin-Protein Ligases/metabolism , Ubiquitination , Zinc Finger Protein GLI1
5.
Semin Cancer Biol ; 34: 3-13, 2015 Oct.
Article in English | MEDLINE | ID: mdl-25794825

ABSTRACT

Lymphomas develop and progress in a specialized tissue microenvironment such as bone marrow as well as secondary lymphoid organs such as lymph node and spleen. The lymphoma microenvironment is characterized by a heterogeneous population of stromal cells, including fibroblastic reticular cells, nurse-like cells, mesenchymal stem cells, follicular dendritic cells, and inflammatory cells such as macrophages, T- and B-cells. These cell populations interact with the lymphoma cells to promote lymphoma growth, survival and drug resistance through multiple mechanisms. Angiogenesis is also recognized as an important factor associated with lymphoma progression. In recent years, we have learned that the interaction between the malignant and non-malignant cells is bidirectional and resembles, at least in part, the pattern seen between non-neoplastic lymphoid cells and the normal microenvironment of lymphoid organs. A summary of the current knowledge of lymphoma microenvironment focusing on the cellular components will be reviewed here.


Subject(s)
Lymphoma/etiology , Lymphoma/pathology , Tumor Microenvironment , Animals , Cell Survival , Endothelial Cells/metabolism , Humans , Lymphoma/metabolism , Lymphoma, B-Cell/etiology , Lymphoma, B-Cell/metabolism , Lymphoma, B-Cell/pathology , Mesenchymal Stem Cells/metabolism , Neovascularization, Pathologic , Signal Transduction , Stromal Cells/metabolism , Stromal Cells/pathology , Tumor Microenvironment/genetics , Tumor Microenvironment/immunology
6.
Oncotarget ; 5(20): 9577-93, 2014 Oct 30.
Article in English | MEDLINE | ID: mdl-25294810

ABSTRACT

Mechanistic target of rapamycin (mTOR) is a central component of the essential signaling pathway that regulates cell growth and proliferation by controlling anabolic processes in cells. mTOR exists in two distinct mTOR complexes known as mTORC1 and mTORC2 that reside mostly in cytoplasm. In our study, the biochemical characterization of mTOR led to discovery of its novel localization on nuclear envelope where it associates with a critical regulator of nuclear import Ran Binding Protein 2 (RanBP2). We show that association of mTOR with RanBP2 is dependent on the mTOR kinase activity that regulates the nuclear import of ribosomal proteins. The mTOR kinase inhibitors within thirty minutes caused a substantial decrease of ribosomal proteins in the nuclear but not cytoplasmic fraction. Detection of a nuclear accumulation of the GFP-tagged ribosomal protein rpL7a also indicated its dependence on the mTOR kinase activity. The nuclear abundance of ribosomal proteins was not affected by inhibition of mTOR Complex 1 (mTORC1) by rapamycin or deficiency of mTORC2, suggesting a distinctive role of the nuclear envelope mTOR complex in the nuclear import. Thus, we identified that mTOR in association with RanBP2 mediates the active nuclear import of ribosomal proteins.


Subject(s)
Cell Nucleus/metabolism , Neoplasms/metabolism , Ribosomal Proteins/metabolism , TOR Serine-Threonine Kinases/metabolism , Active Transport, Cell Nucleus , Cell Line, Tumor , HEK293 Cells , HeLa Cells , Humans , Mechanistic Target of Rapamycin Complex 1 , Mechanistic Target of Rapamycin Complex 2 , Molecular Chaperones/metabolism , Multiprotein Complexes/antagonists & inhibitors , Multiprotein Complexes/deficiency , Multiprotein Complexes/metabolism , Neoplasms/enzymology , Nuclear Pore Complex Proteins/metabolism , Sirolimus/pharmacology , TOR Serine-Threonine Kinases/antagonists & inhibitors , TOR Serine-Threonine Kinases/deficiency
7.
J Biol Chem ; 288(21): 15390-401, 2013 May 24.
Article in English | MEDLINE | ID: mdl-23580656

ABSTRACT

Aberrant activation of Hedgehog signaling has been described in a growing number of cancers, including malignant lymphomas. Here, we report that canonical Hedgehog signaling modulates the transcriptional expression of AKT genes and that AKT1 is a direct transcriptional target of GLI1. We identified two putative binding sites for GLI1 in the AKT1 promoter region and confirmed their functionality using chromatin immunoprecipitation, luciferase reporter, and site-directed mutagenesis assays. Moreover, we provide evidence that GLI1 contributes to the survival of diffuse large B-cell lymphoma (DLBCL) cells and that this effect occurs in part through promotion of the transcription of AKT genes. This finding is of interest as constitutive activation of AKT has been described in DLBCL, but causative factors that explain AKT expression in this lymphoma type are not completely known. In summary, we demonstrated the existence of a novel cross-talk at the transcriptional level between Hedgehog signaling and AKT with biological significance in DLBCL.


Subject(s)
Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Neoplastic , Lymphoma, Large B-Cell, Diffuse/metabolism , Proto-Oncogene Proteins c-akt/biosynthesis , Transcription Factors/metabolism , Transcription, Genetic , Cell Line, Tumor , Cell Survival , Hedgehog Proteins/genetics , Hedgehog Proteins/metabolism , Humans , Lymphoma, Large B-Cell, Diffuse/genetics , Lymphoma, Large B-Cell, Diffuse/pathology , Proto-Oncogene Proteins c-akt/genetics , Signal Transduction/genetics , Transcription Factors/genetics , Zinc Finger Protein GLI1
8.
Ann Hematol ; 92(6): 777-87, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23370596

ABSTRACT

Previously, we have demonstrated that inhibition of Hedgehog pathway induces predominantly apoptosis in diffuse large B-cell lymphoma (DLBCL) cell lines of activated B-cell (ABC) type but predominantly cell cycle arrest in those of germinal center (GC). Here, we explored the possibility of overcoming the resistance to apoptosis to SMO inhibitors in five DLBCL cells of GC type using the combination of the SMO inhibitor HhAntag (Genentech Inc) with the BH3 mimetic ABT-737 (Abbott Laboratories). As controls we have used two DLBCL of ABC type (OCI-LY10 and OCI-LY3). Combinatorial treatments were performed with increasing concentrations of the HhAntag with low doses (equal or less than the IC20) of ABT-737. MTS assays were used to detect changes in cell viability and Annexin-V and PARP1 cleavage assays were used to detect apoptosis. Combining low doses of ABT-737 with increasing concentrations of HhAntag in GC DLBCL cell lines resulted in significantly increase of apoptosis in comparison to treatments with the SMO inhibitor alone. We concluded that in GC DLBCL cell lines, in contrast to those of ABC type, functional inhibition of BCL2 family members is usually needed to overcome the resistance to apoptosis to SMO inhibitors. These findings provide a rationale to explore the use of SMO and BCL2 inhibitors as adjuvant therapy for treatment of DLBCL of GC type.


Subject(s)
Anilides/pharmacology , Apoptosis/drug effects , Biphenyl Compounds/pharmacology , Lymphoma, Large B-Cell, Diffuse/pathology , Neoplasm Proteins/antagonists & inhibitors , Nitrophenols/pharmacology , Proto-Oncogene Proteins c-bcl-2/antagonists & inhibitors , Pyridines/pharmacology , Receptors, G-Protein-Coupled/antagonists & inhibitors , Sulfonamides/pharmacology , Apoptosis Regulatory Proteins/biosynthesis , Apoptosis Regulatory Proteins/genetics , Cell Line, Tumor/drug effects , Cell Line, Tumor/pathology , Dose-Response Relationship, Drug , Drug Resistance, Neoplasm/drug effects , Drug Screening Assays, Antitumor , Drug Synergism , Germinal Center/pathology , Humans , Inhibitory Concentration 50 , Neoplasm Proteins/biosynthesis , Neoplasm Proteins/genetics , Piperazines/pharmacology , Signal Transduction/drug effects , Smoothened Receptor
9.
Small GTPases ; 4(2): 102-5, 2013.
Article in English | MEDLINE | ID: mdl-23354413

ABSTRACT

Rictor's role in cell migration has been first indicated in the original chemotaxis studies in Dictyostelium and more recent studies reported that rictor is required for migration of cancer cells. How rictor promotes cell migration remains poorly characterized. Based on our proteomics study we have identified a novel functional role of rictor in regulation of cell migration. Here, we discuss our recent finding that rictor by suppressing RhoGDI2 maintains activity of the Rac1/cdc42 GTPases and promotes cell migration. Our finding outlines a critical role of rictor in the regulation of RhoGDI2 activity. This study opens new avenues in the investigation of cancer metastasis by analyzing the rictor dependent post-translational modification of RhoGDI2.


Subject(s)
Carrier Proteins/metabolism , Cell Movement/physiology , rho Guanine Nucleotide Dissociation Inhibitor beta/metabolism , Animals , Humans
10.
Int J Biochem Cell Biol ; 43(8): 1187-97, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21554974

ABSTRACT

The thick ascending limb of Henle's loop (TALH) is normally exposed to variable and often very high osmotic stress and involves different mechanisms to counteract this stress. ER resident calcium binding proteins especially calreticulin (CALR) play an important role in different stress balance mechanisms. To investigate the role of CALR in renal epithelial cells adaptation and survival under osmotic stress, two-dimensional fluorescence difference gel electrophoresis combined with mass spectrometry and functional proteomics were performed. CALR expression was significantly altered in TALH cells exposed to osmotic stress, whereas renal inner medullary collecting duct cells and interstitial cells exposed to hyperosmotic stress showed no significant changes in CALR expression. Moreover, a time dependent downregulation of CALR was accompanied with continuous change in the level of free intracellular calcium. Inhibition of the calcium release, through IP3R antagonist, prevented CALR expression alteration under hyperosmotic stress, whereas the cell viability was significantly impaired. Overexpression of wild type CALR in TALH cells resulted in significant decrease in cell viability under hyperosmotic stress. In contrast, the hyperosmotic stress did not have any effect on cells overexpressing the CALR mutant, lacking the calcium-binding domain. Silencing CALR with siRNA significantly improved the cell survival under osmotic stress conditions. Taken together, our data clearly highlight the crucial role of CALR and its calcium-binding role in TALH adaptation and survival under osmotic stress.


Subject(s)
Calcium/metabolism , Calreticulin/metabolism , Loop of Henle/metabolism , Animals , Calcium Signaling , Calreticulin/deficiency , Calreticulin/genetics , Cell Line, Tumor , Cell Membrane Permeability , Cell Survival/physiology , Endoplasmic Reticulum/metabolism , Gene Knockout Techniques , Homeostasis , Humans , Kidney Medulla/cytology , Loop of Henle/cytology , Osmotic Pressure , Proteome/metabolism , Proteomics , Rabbits , Transfection
11.
Phytomedicine ; 18(8-9): 756-9, 2011 Jun 15.
Article in English | MEDLINE | ID: mdl-21211953

ABSTRACT

Epilepsy is a chronic neurological disorder affecting 1% population worldwide. A number of experimental studies have reported anticonvulsant, neuroprotective and antioxidant activity of certain natural products like curcumin, an active ingredient of turmeric. The present study was designed to explore the effect of acute administration of curcumin at doses 50, 100 and 200 mg/kg, orally (p.o.) pentylenetetrazole-induced kindling in mice. Further two oxidative stress markers viz., malondialdehyde (MDA) and glutathione were estimated in brain tissues of rodents. Curcumin (50, 100 and 200 mg/kg, p.o.) dose dependently suppressed the progression of kindling in mice. In addition, the increased levels of MDA and glutathione were also reduced by curcumin in kindled animals. These results suggest that curcumin appears to possess protective activity against kindling in mice.


Subject(s)
Curcumin/pharmacology , Epilepsy/drug therapy , Kindling, Neurologic/drug effects , Oxidative Stress/drug effects , Animals , Anticonvulsants/pharmacology , Curcuma , Disease Models, Animal , Female , Glutathione/metabolism , Male , Malondialdehyde/metabolism , Mice , Mice, Inbred Strains , Phytotherapy , Plant Extracts/pharmacology , Protective Agents/pharmacology
12.
Mol Cancer Res ; 8(6): 896-906, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20501647

ABSTRACT

In animal cells, growth factors coordinate cell proliferation and survival by regulating the phosphoinositide 3-kinase/Akt signaling pathway. Deregulation of this signaling pathway is common in a variety of human cancers. The PI3K-dependent signaling kinase complex defined as mammalian target of rapamycin complex 2 (mTORC2) functions as a regulatory Ser-473 kinase of Akt. We find that activation of mTORC2 by growth factor signaling is linked to the specific phosphorylation of its component rictor on Thr-1135. The phosphorylation of this site is induced by the growth factor stimulation and expression of the oncogenic forms of ras or PI3K. Rictor phosphorylation is sensitive to the inhibition of PI3K, mTOR, or expression of integrin-linked kinase. The substitution of wild-type rictor with its specific phospho-mutants in rictor null mouse embryonic fibroblasts did not alter the growth factor-dependent phosphorylation of Akt, indicating that the rictor Thr-1135 phosphorylation is not critical in the regulation of the mTORC2 kinase activity. We found that this rictor phosphorylation takes place in the mTORC2-deficient cells, suggesting that this modification might play a role in the regulation of not only mTORC2 but also the mTORC2-independent function of rictor.


Subject(s)
Carrier Proteins/metabolism , Signal Transduction/genetics , TOR Serine-Threonine Kinases/metabolism , Threonine/genetics , Animals , Carrier Proteins/genetics , Catalytic Domain/genetics , Cell Line , Cell Line, Tumor , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/metabolism , Fibroblasts/metabolism , HeLa Cells , Humans , Intercellular Signaling Peptides and Proteins/metabolism , Intercellular Signaling Peptides and Proteins/pharmacology , Mice , Mice, Knockout , Phosphatidylinositol 3-Kinases/genetics , Phosphatidylinositol 3-Kinases/metabolism , Phosphorylation/genetics , Proto-Oncogene Proteins c-akt/genetics , Proto-Oncogene Proteins c-akt/metabolism , Rapamycin-Insensitive Companion of mTOR Protein
13.
Mol Cell Proteomics ; 4(10): 1445-58, 2005 Oct.
Article in English | MEDLINE | ID: mdl-15975915

ABSTRACT

Epithelial cells of the thick ascending limb of Henle's loop (TALH cells) play a major role in the urinary concentrating mechanism. They are normally exposed to variable and often very high osmotic stress, which is particularly due to high sodium and chloride reabsorption and very low water permeability of the luminal membrane. It is already established that elevation of the activity of aldose reductase and hence an increase in intracellular sorbitol are indispensable for the osmotic adaptation and stability of the TALH cells. To identify new molecular factors potentially associated with the osmotic stress-resistant phenotype in kidney cells, TALH cells exhibiting low or high levels of resistance to osmotic stress were characterized using proteomic tools. Two-dimensional gel analysis showed a total number of 40 proteins that were differentially expressed in TALH cells under osmotic stress. Twenty-five proteins were overexpressed, whereas 15 proteins showed a down-regulation. Besides the sorbitol pathway enzyme aldose reductase, whose expression was 15 times increased, many other metabolic enzymes like glutathione S-transferase, malate dehydrogenase, lactate dehydrogenase, alpha enolase, glyceraldehyde-3-phosphate dehydrogenase, and triose-phosphate isomerase were up-regulated. Among the cytoskeleton proteins and cytoskeleton-associated proteins vimentin, cytokeratin, tropomyosin 4, and annexins I, II, and V were up-regulated, whereas tubulin and tropomyosins 1, 2, and 3 were down-regulated. The heat shock proteins alpha-crystallin chain B, HSP70, and HSP90 were found to be overexpressed. In contrast to the results in oxidative stress the endoplasmic reticulum stress proteins like glucose-regulated proteins (GRP78, GRP94, and GRP96), calreticulin, and protein-disulfide isomerase were down-regulated under hypertonic stress.


Subject(s)
Gene Expression Profiling , Loop of Henle/cytology , Loop of Henle/metabolism , Proteome/analysis , Proteomics , Animals , Blotting, Western , Cell Shape , Cells, Cultured , Electrophoresis, Gel, Two-Dimensional , Epithelial Cells/cytology , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Gene Expression Regulation , Hydrogen-Ion Concentration , Loop of Henle/drug effects , Loop of Henle/physiopathology , Osmotic Pressure , Proteome/metabolism , Rabbits , Sodium Chloride/pharmacology , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
14.
Article in English | MEDLINE | ID: mdl-15081939

ABSTRACT

The aim of this study was to develop a rapid and sensitive HPLC method with UV detection for the estimation of imatinib from the plasma of patients with chronic myeloid leukemia (CML). The robustness of the method was checked by conducting first dose pharmacokinetics on blood samples from four patients who had been administered Gleevec (100 mg) in an oral dose. Samples were prepared in a simple and single step by precipitating the plasma proteins with methanol and injecting 50 microl aliquot from supernatant was subjected for analysis. Assay was conducted using a C8 column (250 mm x 4.6 mm, 5 microm particle size) under isocratic elution with 0.02 M potassium dihydrogen phosphate-acetonitrile (7:3, v/v) at a flow rate of 1 ml/min and detected using photodiode array at 265 nm. Calibration plots in spiked plasma were linear in a concentration range of 0.05-25 microg/ml. The inter and intra-day variation of standard curve was <4% (R.S.D.). This method could be a simple and quick method for the estimation of imatinib from the patient's plasma.


Subject(s)
Antineoplastic Agents/blood , Chromatography, High Pressure Liquid/methods , Piperazines/blood , Pyrimidines/blood , Spectrophotometry, Ultraviolet/methods , Administration, Oral , Antineoplastic Agents/administration & dosage , Benzamides , Calibration , Humans , Imatinib Mesylate , Neoplasms/blood , Piperazines/administration & dosage , Pyrimidines/administration & dosage , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...